These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 22722952)
61. Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians. Muhammad S; Sani MU; Okeahialam BN Ann Afr Med; 2013; 12(1):24-8. PubMed ID: 23480991 [TBL] [Abstract][Full Text] [Related]
62. Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection. Visnegarwala F; Chen L; Raghavan S; Tedaldi E J Infect; 2005 May; 50(4):331-7. PubMed ID: 15845431 [TBL] [Abstract][Full Text] [Related]
63. Obesity and metabolic abnormalities in offspring of subjects with diabetes mellitus. Praveen EP; Kulshreshtha B; Khurana ML; Sahoo JP; Gupta N; Kumar G; Dwivedi SN; Ammini AC Diabetes Technol Ther; 2010 Sep; 12(9):723-30. PubMed ID: 20707738 [TBL] [Abstract][Full Text] [Related]
65. Comparison of frequency of obesity in high risk non diabetic young individuals with low risk non diabetic young individuals. Shaikh MA; Kumar R; Ghori RA; Shaikh DE J Pak Med Assoc; 2011 Jun; 61(6):522-5. PubMed ID: 22204201 [TBL] [Abstract][Full Text] [Related]
66. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Ledergerber B; Furrer H; Rickenbach M; Lehmann R; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Egger M; Weber R; Clin Infect Dis; 2007 Jul; 45(1):111-9. PubMed ID: 17554711 [TBL] [Abstract][Full Text] [Related]
67. Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study. De Socio GV; Ricci E; Maggi P; Parruti G; Pucci G; Di Biagio A; Calza L; Orofino G; Carenzi L; Cecchini E; Madeddu G; Quirino T; Schillaci G; Am J Hypertens; 2014 Feb; 27(2):222-8. PubMed ID: 24077828 [TBL] [Abstract][Full Text] [Related]
68. Type 2 diabetes in rural and urban population: diverse prevalence and associated risk factors in Bangladesh. Hussain A; Rahim MA; Azad Khan AK; Ali SM; Vaaler S Diabet Med; 2005 Jul; 22(7):931-6. PubMed ID: 15975110 [TBL] [Abstract][Full Text] [Related]
69. Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study. Salomaa VV; Tuomilehto J; Jauhiainen M; Korhonen HJ; Stengård J; Uusitupa M; Pitkanen M; Penttila I Diabetes Care; 1992 May; 15(5):657-65. PubMed ID: 1516486 [TBL] [Abstract][Full Text] [Related]
70. Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women. Danoff A; Shi Q; Justman J; Mulligan K; Hessol N; Robison E; Lu D; Williams T; Wichienkuer P; Anastos K; J Acquir Immune Defic Syndr; 2005 May; 39(1):55-62. PubMed ID: 15851914 [TBL] [Abstract][Full Text] [Related]
71. Rates and Correlates of Incident Type 2 Diabetes Mellitus Among Persons Living With HIV-1 Infection. Ye Y; Shrestha S; Burkholder G; Bansal A; Erdmann N; Wiener H; Tang J Front Endocrinol (Lausanne); 2020; 11():555401. PubMed ID: 33329379 [TBL] [Abstract][Full Text] [Related]
72. Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects. Hofsø D; Jenssen T; Hager H; Røislien J; Hjelmesaeth J Obes Surg; 2010 Mar; 20(3):302-7. PubMed ID: 19949889 [TBL] [Abstract][Full Text] [Related]
73. Screening for impaired glucose tolerance in obese children and adolescents: a validation and implementation study. Morandi A; Maschio M; Marigliano M; Miraglia Del Giudice E; Moro B; Peverelli P; Maffeis C Pediatr Obes; 2014 Feb; 9(1):17-25. PubMed ID: 23296488 [TBL] [Abstract][Full Text] [Related]
74. Sex-differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: the Casale Monferrato Study. Bruno G; Giunti S; Bargero G; Ferrero S; Pagano G; Perin PC Diabet Med; 2004 Aug; 21(8):823-8. PubMed ID: 15270784 [TBL] [Abstract][Full Text] [Related]
75. HIV Infection Is Associated With Type 2 Diabetes Mellitus. Høgh J; Gelpi M; Hove-Skovsgaard M; Afzal S; Nordestgaard BG; Gerstoft J; Benfield T; Storgaard H; Nielsen SD J Acquir Immune Defic Syndr; 2021 Dec; 88(4):e32-e35. PubMed ID: 34520442 [No Abstract] [Full Text] [Related]
76. Prevalence and incidence of diabetes in HIV-infected minority patients on protease inhibitors. Salehian B; Bilas J; Bazargan M; Abbasian M J Natl Med Assoc; 2005 Aug; 97(8):1088-92. PubMed ID: 16173323 [TBL] [Abstract][Full Text] [Related]
77. Are we meeting the American Diabetes Association goals for HIV-infected patients with diabetes mellitus? Adeyemi O; Vibhakar S; Max B Clin Infect Dis; 2009 Sep; 49(5):799-802. PubMed ID: 19635024 [TBL] [Abstract][Full Text] [Related]
78. Trends in diabetes incidence and associated risk factors among people with HIV in the current treatment era. Spieler G; Westfall AO; Long DM; Cherrington A; Burkholder GA; Funderburg N; Raper JL; Overton ET; Willig AL AIDS; 2022 Nov; 36(13):1811-1818. PubMed ID: 35950938 [TBL] [Abstract][Full Text] [Related]
79. Risks of Type 2 diabetes among older people living with HIV: A scoping review. Mhlanga NL; Netangaheni TR S Afr Fam Pract (2004); 2023 May; 65(1):e1-e10. PubMed ID: 37265137 [TBL] [Abstract][Full Text] [Related]
80. Sex differences in type 2 diabetes mellitus prevalence among persons with HIV. Birabaharan M; Strunk A; Kaelber DC; Smith DM; Martin TCS AIDS; 2022 Mar; 36(3):383-389. PubMed ID: 34750292 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]